03-09-2008, 04:14 PM
|
 |
Lecturer
|
� |
Join Date: Apr 2006
Location: Propecia, CA
Posts: 1,848
|
|
Alpha Lipoic Acid May Benefit Those with HIV
Quote:
In a randomized, double-blinded, placebo-controlled trial involving 33 subjects infected with HIV, treatment with alpha-lipoic acid (ALA) was found to significantly increase blood total glutathione levels and improve lymphocyte proliferation response to T-cell mitogens, over a period of 6 months.
Patients were between the ages of 44 and 47 years, 36% nonwhite, with viral loads greater than 10,000 copies/cm(3) despite undergoing highly active antiretroviral treatment (HAART).
Patients were randomized to either receive alpha-lipoic acid (300 mg, 3 times/day), or a placebo. After six months, patients who received ALA were found to have: 1) significant elevations in mean blood total glutathione levels (from 0.81 mmol/L to 1.34 mmol/L), compared with insignificant change found in the placebo group; and 2) significant enhancement or stabilization of lymphocyte proliferation response to T-cell mitogens, compared with a progressive decline found in the placebo group.
In addition, a positive correlation was found between blood total glutathione level and lymphocyte response to anti-CD3 stimulation. No significant differences were found in either HIV RNA level or CD4 count change between the 2 groups.
The authors conclude, "Supplementation with alpha-lipoic acid may positively impact patients with HIV and acquired immune deficiency syndrome by restoring blood total glutathione level and improving functional reactivity of lymphocytes to T-cell mitogens." Additional research into the effects of alpha-lipoic acid supplementation in patients infected with HIV is warranted.
|
https://www.vitasearch.com/get-clp-summary/37161
|
Linear Mode
